Study S002497

Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying: a Prospective Ultrasound Approach with Focus on Perioperative Aspiration Risk.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06659159
Acronym: GLP-1
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 50
Start: 2024-11-01
Primary completion: 2026-10-31
Lead sponsor: Sascha Battig
Conditions: Pulmonary Aspiration During Anaesthetic Induction
Interventions: DIAGNOSTIC_TEST:Gastric ultrasound
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER_GRANT:Hirslanden Klinik

Registered primary outcomes

Gastric content [baseline examination at the first endocrinologic appointment the second examination/data collection will be at the regular endocrinologic control examination 6-8 weeks after therapy initiation. Final examination is 5 months after therapy start]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.